Stock search

Ticker or company name

Compare stocks

Market: US

  • HUMHumana
  • IDXXIdexx Laboratories
  • VEEVVeeva Systems

Add stock

Ticker or company

Summary

HUM
Humana
$461,25Up +2,50%
Year: Up +90%
61/100Ratio would watch
Open stock page
IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Ratio would consider buying
Open stock page
VEEV
Veeva Systems
$299,28Down −0,75%
Year: Up +3%
89/100Best scoreRatio would consider buying
Open stock page

Verdict

VEEV has the best score (89). HUM grows revenue the fastest. HUM is the cheapest by forward P/E. VEEV has the lowest debt load. VEEV has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckHUM5 ✓ 1 — 3 ✕IDXX7 ✓ 1 — 1 ✕VEEV8 ✓ 0 — 1 ✕
P/E vs its history44,047,247,3
P/E vs industry44,047,247,3
Forward P/E26,933,533,6
Revenue growth, YoY+22,0%+11,9%+16,5%
EPS growth, YoY−3,6%+17,7%+25,7%
Net margin0,8%25,4%29,3%
Net debt / EBITDA−4,50,1−7,0
Free cash flow$3,14 bn$1,30 bn$1,67 bn
Share count over a year+0,9%−2,0%−1,6%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterHUMTTMIDXXTTMVEEVTTMIndustry medianTTM
P/E TTM ↓Best: 44,047,2Worst: 47,325,1
Forward P/E ↓Best: 26,933,5Worst: 33,616,2
PEG ↓Best: 1,9Worst: 2,82,12,2
P/S TTM ↓Best: 0,412,0Worst: 13,92,2
EV/EBITDA ↓Best: 20,033,9Worst: 43,217,3
P/FCF ↓Best: 11,0Worst: 42,929,319,5

Price, %

  • HUMn/a
  • IDXXn/a
  • VEEVn/a

Returns

Best WorstNo mark — in between

PeriodHUMIDXXVEEV
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

HUMIDXXVEEV
Share of “buy”Worst: 59%67%Best: 74%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”Best: +9,4%+3,7%Worst: +3,4%
Insiders over 12 monthssales $2,43 msales $58,4 msales $16,8 m

Details are on each stock page.